Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Latham Group Reports Q2 2026 Financial Results

Latham Group, Inc. filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the fiscal quarter and two fiscal quarters ended June 27, 2026.

Nitish Kishor | 05 August 2026

Rapport Therapeutics Files Q2 2026 Quarterly Report

Rapport Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting on its financial condition and operations as a clinical-stage biotechnology company.

Manish Choudhary | 05 August 2026

Dine Brands Global Files Q2 2026 Form 10-Q

Dine Brands Global, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter ended June 28, 2026.

Nitish Kishor | 05 August 2026

Lakeland Financial Posts Q2 2026 Earnings Results

Lakeland Financial Corporation, a Indiana-based bank holding company trading on the Nasdaq Global Select Market as LKFN, filed its Form 10-Q for the quarterly period ended June 30, 2026, on August 5, 2026, disclosing net income, balance sheet changes, and income statement details for …

Anjali Anand | 05 August 2026

NCR Voyix Posts Q2 2026 Results in 10-Q Filing

NCR Voyix Corporation (NYSE: VYX) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the three and six months ended June 30, 2026.

Aakashdeep | 05 August 2026

Holley Inc. Posts Q2 2026 Quarterly Financial Report

Holley Inc. filed its Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 28, 2026, disclosing condensed consolidated balance sheet figures and other financial information as of that date.

Vinay Lochav | 05 August 2026

Bioventus Discloses Q2 2026 Results and Strategic Review

Bioventus Inc. filed a Form 8-K with the SEC on August 5, 2026, announcing its financial results for the three and six months ended June 27, 2026, and providing an update on its ongoing strategic alternatives review process.

Aakashdeep | 05 August 2026

Immuneering Corporation Files Q2 2026 Form 10-Q

Immuneering Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended June 30, 2026, disclosing financial statements, risk factors, and operational updates for the three and six months ended June 30, 2026.

Aditi Sarkar | 05 August 2026

Zeta Global Holdings Files Q2 2026 Quarterly Report

Zeta Global Holdings Corp. filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission on August 5, 2026, covering the quarterly period ended June 30, 2026.

Vinay Lochav | 05 August 2026

Vishay Intertechnology Q2 2026 Quarterly Results

Vishay Intertechnology, Inc. filed its Form 10-Q with the Securities and Exchange Commission on August 5, 2026, covering the fiscal quarter and six fiscal months ended July 4, 2026.

Nitish Kishor | 05 August 2026
Support

Hi! How can we help you today?

Loading…